Clinical Trial Update: Evaluating Buspirone to Treat Opioid Withdrawal [Phase 2]

View source ↗

Summary

An ongoing Phase 2 study at Johns Hopkins is evaluating buspirone for treating opioid withdrawal symptoms in people with opioid use disorder, with potential eff…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Opioid Craving
• Opioid Use Disorder
• Opioid Withdrawal

Drugs mentioned

• Buspirone (buspirone)

Snippet

Sponsor: Johns Hopkins University | Conditions: Opioid Use Disorder, Opioid Withdrawal | Phase 2 | Status: ACTIVE_NOT_RECRUITING